Wanbury logo

Wanbury PE ratio, market cap and valuation

NSE: WANBURYBSE: 524212Pharmaceuticals & BiotechnologySmall Cap

Last close ₹178.47down ₹7.30 (3.93%)BSE ₹178.50

Share price at the NSE close on 23 Oct 2026. Previous close ₹185.77.

52-week range of traded prices to 23 Oct 2026
₹161.50Low, 27 Jan 2026₹358.85High, 15 Jul 2026
Market cap
₹624 Cr1,555th largest listed
P/E
11.2
P/B
4.3
Dividend yield
Nonein the last 12 months
ROE
54.9%
ROCE
23.3%
Debt to equity
1.49
Volume, NSE
1,89,22045.6% delivered

Wanbury PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The ratios are on standalone accounts to Mar 2020, consolidated accounts Mar 2021 to Mar 2025 and standalone from Mar 2026. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earnings11.17today

    1 year

    Median 14.63

    Today is at or above 0.4% of the 247 days

    3 years

    Median 21.33

    Today is at or above 0.1% of the 744 days

  • Price to book4.32today

    1 year

    Median 7.22

    Today is at or above 0.5% of the 211 days

    3 years, since Jun 2024

    Median 15.36

    Today is at or above 0.2% of the 542 days

  • Price to sales0.96today

    1 year

    Median 1.35

    Today is at or above 1% of the 247 days

    3 years

    Median 1.32

    Today is at or above 24% of the 744 days

    5 years

    Median 0.89

    Today is at or above 54% of the 1,235 days

    10 years

    Median 0.39

    Today is at or above 76% of the 2,392 days

  • EV to EBITDA8.44today

    1 year

    Median 10.32

    Today is at or above 1% of the 211 days

    3 years

    Median 10.93

    Today is at or above 6% of the 693 days

    5 years

    Median 10.38

    Today is at or above 18% of the 1,162 days

  • Dividend yield0.00%today

    1 year

    Median 0.00%

    Today is at or above 100% of the 247 days

    3 years

    Median 0.00%

    Today is at or above 100% of the 744 days

    5 years

    Median 0.00%

    Today is at or above 100% of the 1,240 days

    10 years

    Median 0.00%

    Today is at or above 100% of the 2,477 days

  • Earnings yield8.96%today

    1 year

    Median 6.83%

    Today is at or above 100% of the 247 days

    3 years

    Median 5.88%

    Today is at or above 95% of the 744 days

    5 years

    Median 5.96%

    Today is at or above 77% of the 1,235 days

    10 years

    Median 2.37%

    Today is at or above 78% of the 2,392 days

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 11 AugThe balance sheet: Filed 29 May

  • Price to earnings =Market cap÷Net profit, last twelve months₹56 Cr
  • Price to book =Market cap÷Net worth₹144 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹653 Cr
  • Enterprise value =Market cap+Borrowings₹215 Cr−Cash₹7.63 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹99 Cr
  • Market cap =Close×Shares in issue3,49,66,928at 30 Sep 2026

Standalone accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Wanbury financials ›

Wanbury valuation at each year end

On the last trading day of each March, the month the company's year ends.Wanbury dividend history

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Market cap (₹ crore)116745143206276122479768774
Price to earningsLossLossLossLoss3.5Loss1.720.517.512.0
Price to bookNo balance sheetNo balance sheetNegative net worthNegative net worthNegative net worthNegative net worthNegative net worthNegative net worth19.87.2
Price to sales0.30.20.10.10.60.60.20.81.41.2
EV to EBITDANo balance sheetOperating lossOperating loss4.826.218.48.28.714.89.0
Dividend yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Earnings yield−0.5%−34.1%−54.8%−18.0%28.5%−3.6%58.3%4.9%5.7%8.4%
A ratio that does not exist on the day says why in its cell. The ratios are on standalone accounts to Mar 2020, consolidated accounts Mar 2021 to Mar 2025 and standalone from Mar 2026.

Wanbury market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹832 Cr
P/E to growth
0.37
Earnings per share
₹15.98
Book value per share
₹41.31
Dividends, last 12 months
None
Public's market cap
₹356 Cr

Against Pharmaceuticals

216 listed companies in Pharmaceuticals, each priced on its last trading day; Wanbury is 103rd among them by market cap. Each median leaves out Wanbury itself and takes the other companies that have the figure.

Industry median P/E
28.3Across 155 other companies
Industry median P/B
2.8Across 186 other companies
Industry median EV/EBITDA
18.7Across 141 other companies
Industry median dividend yield
0.53%Across 89 other companies